Estimate eczema severity with a fast, structured EASI score from 0 to 72. Enter lesion intensity and affected area for each body region, then calculate a weighted total score with a clear severity interpretation.
| Body Region | Erythema 0-3 |
Edema/Papulation 0-3 |
Excoriation 0-3 |
Lichenification 0-3 |
Area % 0-100 |
|---|---|---|---|---|---|
| Head/Neck | |||||
| Trunk | |||||
| Upper Limbs | |||||
| Lower Limbs |
Area scoring is converted automatically: 0%=0, 1-9%=1, 10-29%=2, 30-49%=3, 50-69%=4, 70-89%=5, 90-100%=6.
The EASI calculator is a practical way to estimate disease severity in atopic dermatitis (eczema) using a standardized framework. EASI stands for Eczema Area and Severity Index. It combines two core elements: how intense visible signs are and how much body surface is affected. The final score ranges from 0 to 72, where higher values indicate more severe disease activity.
Clinicians, researchers, and care teams rely on EASI because it is structured, reproducible, and widely used in treatment studies. Patients and caregivers often find EASI useful as well, especially when they want to track trends over time and discuss progress with a dermatologist. While the score is not a standalone diagnosis tool, it supports better communication and objective follow-up in real-world care.
EASI evaluates four signs of inflammation in four body regions. Each sign is scored from 0 to 3 for each region, then combined with an area involvement score and regional weighting factors. The signs are:
The body is split into these regions with different multipliers:
Because lower limbs and trunk represent larger body proportions in the EASI model, they influence the total score more strongly when heavily involved.
This page performs the standard EASI method in a streamlined format:
This method reflects the same logic used in trials and many specialist settings. The output includes a score and a severity label to help with quick interpretation.
Interpretation thresholds vary slightly across publications and protocols, but commonly used categories are:
These ranges are useful as a communication framework. In routine care, clinicians also consider itch, sleep disruption, quality of life, infection risk, treatment adherence, and response durability over time.
Atopic dermatitis is highly variable. Symptoms can flare and settle, and visible findings can differ by age, skin tone, season, and treatment stage. Without a structured index, it can be difficult to compare visits accurately. A validated scale like EASI helps reduce subjectivity by giving the same scoring logic at each assessment.
For patients, this structure helps answer practical questions: Is treatment working? Is inflammation truly improving, or only itch? Is disease control stable or fluctuating? Measured trends can support treatment adjustments, adherence conversations, and shared decision-making.
A single EASI value is useful, but trend data is often more meaningful. In longitudinal care, repeated measurements can help identify:
In clinical trials, relative change metrics such as EASI-50, EASI-75, and EASI-90 are commonly used to report improvement versus baseline. For example, EASI-75 indicates a 75% reduction from initial score, often interpreted as a strong clinical response.
To improve reliability, use consistent scoring habits and document context at each visit. If multiple clinicians are involved, shared calibration examples can reduce inter-rater variation.
EASI is not the only method used in atopic dermatitis. Depending on clinical goals, teams may also use SCORAD, POEM, IGA, itch scales, and quality-of-life questionnaires. Each tool captures different dimensions:
In practice, objective and patient-reported outcomes complement each other. A lower EASI can coexist with persistent itch or sleep disruption, so treatment decisions should integrate the full clinical picture.
Dermatologists, allergists, pediatric specialists, nurse practitioners, physician assistants, research coordinators, and trained students can use EASI tools to support structured assessments. Patients and caregivers can also use a calculator for education and visit preparation, but final interpretation should come from qualified clinicians.
With these habits, EASI becomes a strong monitoring metric for chronic eczema management.
This EASI calculator is intended for educational and clinical support purposes. It does not diagnose eczema, determine etiology, or replace clinician judgment. If disease is rapidly worsening, signs of skin infection are present, or symptoms are significantly affecting sleep and function, seek medical evaluation promptly.
Yes, higher values generally indicate greater objective eczema severity. However, symptom burden may not perfectly match lesion severity, so patient-reported outcomes remain important.
Yes, EASI is widely used across age groups. In pediatric care, interpretation still requires clinical context, including distribution patterns and quality-of-life impact.
The maximum possible score is 72, based on the highest severity and area values in all body regions.
No. EASI measures visible clinical signs and affected area. Itch and sleep are assessed through additional patient-reported tools.